Kliniken und Institute


Klinik für Neurologie


Bähr

Leitung

Direktor
Prof. Dr. Mathias Bähr

Sekretariat

Telefon: +49 (0) 551 39-666 03, 39-666 84
Fax: +49 (0) 551 39-93 48
E-Mail: neurolog@med.uni-goettingen.de

Patientenanmeldung

Telefon: 0551-39-98 89

Anschrift

Robert-Koch-Str. 40
37075 Göttingen

Briefpostadresse

37099 Göttingen

Homepage

URL / Homepage www.neurologie.med.uni-goettingen.de

Downloads

PDF Publikationen 2015 2014 2013 2012 2011

PDF Qualitätsbericht 2013 2010 2008

Ausgewählte Publikationen
  • Llorens F, Schmitz M, Karch A, Cramm M, Lange P, Gherib K, Varges D, Schmidt C, Zerr I, Stoeck K (2015) Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. ALZHEIMERS DEMENT in press: in press, doi: 10.1016/j.jalz.2015.10.009 [IF 11,6]. 
  • Sharma K, Schmitt S, Bergner CG, Tyanova S, Kannaiyan N, Manrique-Hoyos N, Kongi K, Cantuti L, Hanisch UK, Philips MA, Rossner MJ, Mann M, Simons M (2015) Cell type- and brain region-resolved mouse brain proteome. NAT NEUROSCI 18(12): 1819-31, doi: 10.1038/nn.4160 [IF 16,1]. 
  • Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F (2014) Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. LANCET NEUROL 13(2): 150-8, doi: 10.1016/S1474-4422(13)70307-7 [IF 21,9]. 
  • Schweingruber N, Fischer HJ, Fischer L, van den Brandt J, Karabinskaya A, Labi V, Villunger A, Kretzschmar B, Huppke P, Simons M, Tuckermann JP, Flügel A, Lühder F, Reichardt HM (2014) Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses. ACTA NEUROPATHOL 127(5): 713-29, doi: 10.1007/s00401-014-1248-4 [IF 10,7].
  • Doeppner TR, Kaltwasser B, Sanchez-Mendoza EH, Caglayan AB, Bähr M, Hermann DM (2016) Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways. J Cereb Blood Flow Metab. 2016 Apr 28. pii: 0271678X16647738. [Epub ahead of print] [IF 5,4].

Suchworte: Demenz, Multiple Sklerose, Morbus Parkinson, Schlaganfall